ANA TORRES ALVAREZ: Open Payments
NPI 1689382863 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $327 |
| Amgen Inc. | 5 | $87 |
| ABBVIE INC. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, Ozempic, Rybelsus, OTEZLA, VRAYLAR, Kerendia, ELIQUIS, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
